[1] 吕威,刘静.吸烟与牙周病关系研究综述[J].赤峰学院学报,2011, 27(7):44-46.
[2] 吴莹莹,刘洪臣.TNF-α、IL-1β及IL-6与糖尿病及牙周炎之间的关系[J].中华老年口腔医学杂志,2011,9(2):117-121.
[3] 戴丽娜.牙周炎性牙槽骨吸收与T细胞间的关系[J].国际口腔医学杂志,2012,39(2):241-247.
[4] 孙艳楠.吸烟大鼠实验性牙周炎动物模型的建立[D].山东:青岛大学,2011.
[5] Kenney EB,Saxe SR,Bowles RD.The relationship of manual dexterity and knowledge to performance of oral hygiene. Periodontol.1975;46(1):82
[6] 孙晓强,刘晓勇,王瑛弢,等.吸烟对牙周炎患者牙龈组织中成纤维细胞及胶原纤维的影响[J].北京口腔医学,2006,14(1):27-29.
[7] Van der Velden U, Varoufaki A, Hutter JW, et al. Effeet of smoking and periodontal treatment on The Subgingival microflora.J Clin Periodontol.2003;30(7):603-610.
[8] 雷光华,高曙光,覃芙,等.吸烟者与不吸烟者骨组织骨桥蛋白表达的差异[J].国际骨科学杂志,2008,29(5):330-332.
[9] César-Neto JB, Benatti BB, Sallum EA, et al. The influence of cigarette smoke inhalation and its cessation on the tooth -supporting alveolar bone:A histometric study in rats. J Periodontal Res.2006;41(2):118-123.
[10] 徐莉,B.G Loos.牙槽骨吸收与吸烟状况的研究[J].实用口腔医学杂志,2005,21(2):157-159.
[11] Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin: A novel secreted protein involved in the regulation of bone density.Cell.1997;89(2):309 -319.
[12] Laey DL,Timms E,Tan HL,et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell.1998;93(2):165-176.
[13] 李春年,李淑娟,杨冬茹,等.左归丸对实验性骨质疏松牙周炎大鼠牙周组织OPG、RANKL表达的影响[J].实用口腔医学杂志, 2011, 27(2):270-273.
[14] 孟微,陈远萍,陈冲,等.辛伐他汀对牙周炎大鼠牙移动保持阶段 OPG表达影响的实验研究[J].口腔医学研究,2011,27(12): 1052-1055.
[15] 郭子杰,金军华,张铁梅,等.大鼠牙龈组织表达护骨因子和护骨因子配体[J].现代口腔医学杂志,2002,16(4):289-291.
[16] 刘艳春,陈诚,逯宜,等.不同剂量氟中毒大鼠拔除左侧上颌磨牙后剩余牙槽骨中OPG/OPGL的表达[J].山西医科大学学报, 2013, 44(9):694-697.
[17] Fuller K,Wong B,Fox S,et al. TRANCE is necessary and sufficient for osteoblast mediated activation of bone resorption in osteoclasts. J Exp Med.1998;188(5): 997-1001.
[18] 刘棋,David Haynes,Mark Bartold,等.慢性牙周炎中核因子κB受体活化子,护骨素和肿瘤坏死因-α的蛋白表达[J].口腔医学, 2004,24(6):347-349.
[19] 杜宁.被动吸烟对实验性牙周炎大鼠牙周组织的影响[D].石家庄:河北医科大学,2012.
[20] 赵戬,马勇强,王宏岩,等.大鼠实验性牙周炎模型牙槽骨破坏研究[J].中国实用口腔科杂志,2012,5(3):155-158.
[21] Nile CJ, Sherrabeh S, Ramage G, et al. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease.J Clin Periodontol. 2013; 40(9):875-882.
[22] Ozçaka O, Nalbantsoy A, Köse T,et al.Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients.Aust Dent J. 2010;55(4):405-410.
[23] Buduneli N, Buduneli E, Kütükçüler N.Interleukin-17, RANKL, and osteoprotegerin levels in gingival crevicular fluid from smoking and non-smoking patients with chronic periodontitis during initial periodontal treatment.J Periodontol.2009;80(8): 1274-1280.
[24] Tang TH, Fitzsimmons TR, Bartold PM.Effect of smoking on concentrations of receptor activator of nuclear factor kappa B ligand and osteoprotegerin in human gingival crevicular fluid.J Clin Periodontol. 2009;36(9):713-718.
[25] Sakellari D, Menti S, Konstantinidis A.Free soluble receptor activator of nuclear factor-kappab ligand in gingival crevicular fluid correlates with distinct pathogens in periodontitis patients. J Clin Periodontol.2008;35(11):938-943.
[26] Lappin DF, Sherrabeh S, Jenkins WM, et al.Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients.J Clin Periodontol. 2007;34(4):271-277. |